Recurrent Guillian Barre’ Syndrome vs acute onset CIDP - study of 2 cases.
DOI:
https://doi.org/10.17161/rrnmf.v5i1.20953Keywords:
Recurrent GBS, Acute onset CIDP, Paranodopathies, RituximabAbstract
The most common acquired immune mediated polyneuropathies are acute inflammatory demyelinating polyradiculoneuropathy(AIDP), a form of Gullian Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy(CIDP). Sixteen percent of CIDP patients may present acutely like AIDP, developing in less than 8 weeks. Also GBS which is usually monophasic can have recurrences . Distinguishing Acute onset CIDP(A-CIDP) and recurrent AIDP may be difficult in early stages but may be crucial to guide the treatment strategies.
Downloads
References
Grand’Maison F, Feasby TE, Hahn AF, et al. Recurrent Guillain–Barre´ syndrome. Clinical and laboratory features. Brain 1992;115:1093–1106.
Das A, Kalita J, Misra UK. Recurrent Guillain–Barre´ syndrome. Electromyogr Clin Neurophysiol 2004;44:95–10
Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol. 2014;10:435–446. doi: 10.1038/nrneurol.2014.117.
Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat. Rev. Neurol. 2011;7:507–517. doi: 10.1038/nrneurol.2011.121
Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010 May;74(21):1680–6.
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33.
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51(4):1110–5.
Alessandro L, Rueda JMP, Wilken M, et al. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) and acute inflammatory demyelinating polyneuropathy (AIDP) in adult patients. J Peripher Nerv Syst. 2018;
Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010; 41(2): 202- 207.
Van den Bergh PYK , van Doorn PA , Jacobs BC , Querol L , Bunschoten C , Cornblath DR. Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2020;25(1):4–8
Querol L, Rojas-García R, Diaz-Manera J, Barcena J, Pardo J, Ortega,et-al. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e149
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Sankalp Mohan DM , Megha Dhamne MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
